Veru (VERU)
Develops oral candidates for obesity-related body composition and atherosclerotic inflammation.
$2.75
Pre-market+0.01 (+0.38%)
At close$2.74(+1.86%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions69 holders · as of Jun 30, 2026 | 17.78% | 3.03M shares | |
| Insiders2 holders · as of Aug 17, 2026 | 0.16% | 27.3K shares | |
| Otherremainder | 82.06% | 13.99M shares |
17.05M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Institutions13F, as of Jun 30, 2026
69 holders · 3.03M shares · 14 new positions · 28 increased · 13 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 698.4K | 4.10% | +159.1K | Aug 13, 2026 |
| Alyeska Investment Group, L.P. | 238.6K | 1.40% | −761.4K | Aug 14, 2026 |
| Oppenheimer & Co Inc | 210.8K | 1.24% | +14.5K | Aug 3, 2026 |
| BlackRock, Inc. | 167.1K | 0.98% | +52.9K | Aug 7, 2026 |
| Renaissance Technologies LLC | 164.5K | 0.96% | +95.2K | Aug 13, 2026 |
| Gsa Capital Partners LLP | 157.3K | 0.92% | −32.4K | Aug 6, 2026 |
| Geode Capital Management, LLC | 155.1K | 0.91% | −29.5K | Aug 12, 2026 |
| Summit Financial, LLC | 141.9K | 0.83% | −9.9K | Aug 12, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 9.90% | 1.59M | 13G | Feb 17, 2026 ↗ |
| BlackRock, Inc. | 5.60% | Nov 8, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 13, 2026 | K. Gary Barnetteofficer: Chief Scientific Officer | Purchase | 1,800 | $2.69 | 2,300 |
CongressHouse and Senate disclosures
Not reported.